Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 3 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Managing job execution
System and method for providing a path avoidance feature in a network environment
Lithographic apparatus and device manufacturing method
Method and apparatus for image sensor packaging
Image enhancement based on multiple frames and motion estimation
Apparatus and method for evaluating an activity distribution, and irradiation system
Dual-box location aware and dual-bitmap voltage domain aware on-chip variation techniques
  Randomly Featured Patents
Focus adjustment method of zoom lens system
Linear drive scroll compressor assemble
Digital chrominance separating and processing system and method
Offset printing ink
Catheter having a multiple locking mechanism
Closable bag and method and arrangement for aseptic filling thereof
Automatic dosing device with a dosing screw and the use of such an automatic dosing device
Waved clutch piston ring
Cloning of transgenic unglulates comprising artificial chromosomes
Lens drive mechanism